Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (363)	2/4/1999 3:11:00 PM
From: aknahow	Read Replies (2) \| Respond to of 712

If "Institutions" really own 70% of CORR trades by individuals with the remaining float have been for me at least "noise". Each time I felt I was hearing something meaningful I later found out it certainly did not mean what I thought it did. If sales really ramp up and the pharmas themselves see how, why and when Integrilin will have a significant market presence, I do see CORR as a likely takeover target. Lots of if in this post. Sort of like saying, if it becomes a takeover target it will be taken over.